Literature DB >> 26614735

Molecular Insights into the Pathogenesis of IgA Nephropathy.

Thomas Robert1, Laureline Berthelot2, Alexandra Cambier3, Eric Rondeau3, Renato C Monteiro4.   

Abstract

Immunoglobulin IgA nephropathy (IgAN) is the leading form of primary glomerulonephritis associated with end-stage renal failure, requiring either dialysis or renal transplantation. Microscopic hematuria and proteinuria are the most common presentations, and mesangial cell proliferation with IgA deposition are found in renal biopsies. There is growing evidence that IgAN is an immune complex (IC)-mediated disease. To date, three key molecules have been implicated in IC formation, correlating with disease progression/recurrence after transplantation: galactose-deficient IgA1 (Gd-IgA1), IgG anti-Gd-IgA1 antibodies, and soluble CD89 (an Fc receptor for IgA). This review examines recent data on the role of these molecular players in IgAN. Understanding these factors is essential because such knowledge could lead to improved strategies for the future management of patients with IgAN.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26614735     DOI: 10.1016/j.molmed.2015.10.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  25 in total

Review 1.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

Review 2.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

3.  Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.

Authors:  Xuxiang Sheng; Xiaoyan Zuo; Xihui Liu; Yang Zhou; Xia Sun
Journal:  Int Urol Nephrol       Date:  2017-12-11       Impact factor: 2.370

4.  [Clinical and pathological features in IgA nephropathy with IgG deposition in the glomerular mesangial area].

Authors:  Xiao-Meng Xu; Shuang-Shuang Zhu; Xiao-Hong Wang; Xiao-Fei Shao; Bin Li; Ying Zhang; Qin Liu; Jia-Min Li; Hong-Lei Wang; Yong-Qiang Li; He-Qun Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

5.  Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.

Authors:  Peidi Liu; Emelie Lassén; Viji Nair; Celine C Berthier; Miyuki Suguro; Carina Sihlbom; Matthias Kretzler; Christer Betsholtz; Börje Haraldsson; Wenjun Ju; Kerstin Ebefors; Jenny Nyström
Journal:  J Am Soc Nephrol       Date:  2017-06-23       Impact factor: 10.121

Review 6.  New therapeutic perspectives for IgA nephropathy in children.

Authors:  Alexandra Cambier; Patrick J Gleeson; Héloise Flament; Marie-Bénédicte Le Stang; Renato C Monteiro
Journal:  Pediatr Nephrol       Date:  2020-02-10       Impact factor: 3.714

7.  Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy.

Authors:  Jie Wei; Yan Wang; Xiangming Qi; Yonggui Wu
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

8.  Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.

Authors:  Magdalena Krochmal; Katryna Cisek; Szymon Filip; Katerina Markoska; Clare Orange; Jerome Zoidakis; Chara Gakiopoulou; Goce Spasovski; Harald Mischak; Christian Delles; Antonia Vlahou; Joachim Jankowski
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

9.  Biomarkers of IgA vasculitis nephritis in children.

Authors:  Evangeline Pillebout; Agnès Jamin; Hamza Ayari; Pierre Housset; Melissa Pierre; Virginia Sauvaget; Denis Viglietti; Georges Deschenes; Renato C Monteiro; Laureline Berthelot
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

Review 10.  Tuberculosis-associated IgA nephropathy.

Authors:  Yamei Wang; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.